Cargando…
The Effects of Health Anxiety and Litigation Potential on Symptom Endorsement, Cognitive Performance, and Physiological Functioning in the Context of a Food and Drug Administration Drug Recall Announcement
Drug recalls and lawsuits against pharmaceutical manufacturers are accompanied by announcements emphasizing harmful drug side-effects. Those with elevated health anxiety may be more reactive to such announcements. We evaluated whether health anxiety and financial incentives affect subjective symptom...
Autores principales: | Lecci, Len, Page, Gary Ryan, Keith, Julian R., Neal, Sarah, Ritter, Ashley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236552/ https://www.ncbi.nlm.nih.gov/pubmed/35769761 http://dx.doi.org/10.3389/fpsyg.2022.818724 |
Ejemplares similares
-
Rethinking the Threats to Scientific Balance in Contexts of Litigation and Regulation
por: Freudenburg, William R.
Publicado: (2008) -
An Analysis of Foot and Ankle Device Recalls by the Food and Drug Administration
por: Pellerin, Carl, et al.
Publicado: (2018) -
Legal and health variations in drug litigation injunctions granted in Minas Gerais
por: Coelho, Tiago Lopes, et al.
Publicado: (2014) -
The High “Cost” of Experimental Drugs Obtained Through Health Litigation in Brazil
por: da Silva, Ricardo Eccard, et al.
Publicado: (2020) -
Vulcanite Litigation
por: White, Samuel S.
Publicado: (1874)